A Discussion: Rising NAS Rates are Associated with Rising Buprenorphine Prescription Numbers

In this podcast, Southern Medical Journal (SMJ) Editor-in-Chief Dr. Steven Baldwin is joined by Dr. Martin Olsen to discuss the topic of “Rise in Rate of Neonatal Abstinence Syndrome is Associated with Rise in Buprenorphine Prescription Numbers”.

Posted in: buprenorphine 8 neonatal abstinence syndrome 7 opioids 10 Southern Medical Journal 9

Original Article

CME Article: Rise in Neonatal Abstinence Syndrome Rate Is Associated with Increase in Buprenorphine Prescription Numbers

Objectives: Southern Appalachia is a region of the United States that is disproportionately affected by the opioid epidemic and by increasing rates of neonatal abstinence syndrome (NAS). NAS rates increased approximately 400% between 1999 and 2012. Buprenorphine prescriptions written to treat opioid use disorder also increased dramatically. The present study…

Posted in: buprenorphine 8 medication-assisted therapy 3 neonatal abstinence syndrome 7 pregnancy 48

Original Article

Prevention of Neonatal Abstinence Syndrome in an Outpatient Prenatal Buprenorphine Tapering Program

Objectives: Many addicted pregnant patients receiving buprenorphine medication-assisted therapy (MAT) wish to discontinue this medication while pregnant. This study was undertaken to determine whether outpatient detoxification from buprenorphine during pregnancy is safe and effective when confirmed with postdetoxification urine drug screens (UDSs). Methods: This case series reports the maternal and…

Posted in: medication-assisted therapy 3 neonatal abstinence syndrome 7 pregnancy 48

Original Article

Perceived Barriers to Contraceptive Access and Acceptance among Reproductive-Age Women Receiving Opioid Agonist Therapy in Northeast Tennessee

Objectives: Women with substance use disorders experience unique challenges to contraceptive obtainment and user-dependent method adherence, contributing to higher than average rates of unintended pregnancy. This study estimated the prevalence of barriers to contraception and their associations with contraceptive use and unwanted pregnancies among women receiving opioid agonist therapy (OAT)…

Posted in: contraception 15 neonatal abstinence syndrome 7 opioid use disorder 6 reproductive health 9

Original Article

Healthcare Access, Pregnancy Intention, and Contraceptive Practices Among Reproductive-Aged Women Receiving Opioid Agonist Therapy in Northeast Tennessee

Objectives: Women with substance use disorders often experience unique challenges to obtaining contraception and adhering to user-dependent methods. As a result, this at-risk population of women tends to have higher than average rates of unintended pregnancy. The objective of this study was to describe contraceptive use, pregnancy intentions, and adequacy…

Posted in: contraception 15 neonatal abstinence syndrome 7 opioid use 2 reproductive health 9

Original Article

Newborn Congenital Malformations Associated With Prenatal Exposure to Drugs in Kentucky, 2009–2013

Objectives: This study examined associations between prenatal drug exposures and congenital organ system malformation diagnoses in newborns (at birth) and infants (hospitalizations after birth up to 30 days of age) in Kentucky. Methods: Data were obtained from Kentucky inpatient hospitalization records for newborns and for infants from 2009 to 2013….

Posted in: neonatal abstinence syndrome 7 pregnancy 48

Original Article

Prenatal Care, Pregnancy Outcomes, and Postpartum Birth Control Plans Among Pregnant Women with Opiate Addictions

Objectives: To describe how effectively we provided adequate prenatal care and postpartum contraception to prevent repeat, unintended pregnancies to women using opiates or medication maintenance therapy (MMT) during pregnancy. Methods: We conducted a retrospective chart review of 94 women using opiates or MMT during 96 pregnancies while receiving prenatal care…

Posted in: neonatal abstinence syndrome 7 postpartum contraception 2
SMA Menu